Lyfe Capital, a Chinese healthcare-focused private equity firm, has closed its debut fund at US$298 million to make early-stage equity investments in the the pharmaceuticals, medical device, digital healthcare, diagnostics sectors in China, according to a company announcement. The fund is made of two vehicles, a US$210 million U.S. dollar fund and a RMB555 million […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.